CureVac - International Biopharmaceutical Industry

Current Edition

Issue 9, Volume 3

Current Features

Issue 9, Volume 3

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

news

CureVac scraps its first COVID-19 vaccine and pivots to a second

After months sticking with its coronavirus vaccine, CureVac has finally given up. CureVac executives had long argued the shot could still play a role in fighting COV...

15 October 2021 news aged 18-60 | Biotech

Continue Reading →

news

CureVac scales back mRNA manufacturing for coronavirus vaccine

While not acknowledged directly, the "corresponding changes in demand" could also stem from disappointing clinical trial results CureVac released for its vaccine in m...

17 September 2021 news coronavirus vaccine | CureVac

Continue Reading →